Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells

被引:140
|
作者
Nachshon-Kedmi, M
Yannai, S [1 ]
Haj, A
Fares, FA
机构
[1] Technion Israel Inst Technol, Fac Food Engn & Biotechnol, IL-32000 Haifa, Israel
[2] Carmel Hosp, Dept Biochem & Mol Genet, Haifa, Israel
关键词
apoptosis; diindolylmethane; indole-3-carbinol; prostate cancer;
D O I
10.1016/S0278-6915(03)00004-8
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Cruciferous vegetables contain glucobrassicin which, during metabolism, yields indole-3-carbinol (I3C). In a low pH environment I3C is converted into polymeric products, among which 3,3'-diindolylmethane (DIM) is the main one. The apoptotic effects of I3C and DIM were exhibited in human breast cancer cells. The objectives of this study were: (a) examination of the potential effects of I3C and DIM on the proliferation and induction of apoptosis in human prostate cancer cell lines with different p53 status; (b) to try to characterise the mechanism(s) involved in these effects. Our results indicate that both indole derivatives suppress the growth of these cells in a dose- and time-dependent manner, by inducing apoptosis. It appears that these indolic compounds may offer effective means against prostate cancer. Induction of apoptosis was p53-independent. Moreover, the indole derivatives employed did not affect the levels of bcl-2, bax and fasL. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [1] 3,3′-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells
    Beaver, Laura M.
    Yu, Tian-Wei
    Sokolowski, Elizabeth I.
    Williams, David E.
    Dashwood, Roderick H.
    Ho, Emily
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 263 (03) : 345 - 351
  • [2] THE USE OF INDOLE-3-CARBINOL AND ITS METABOLITE 3,3′-DIINDOLYLMETHANE IN GYNECOLOGY
    Dosedla, Erik
    Turcsanyiova, Zuzana
    [J]. AKTUALNI GYNEKOLOGIE A PORODNICTVI, 2020, 12 : 40 - 45
  • [3] Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane
    Williams, David E.
    [J]. FRONTIERS IN NUTRITION, 2021, 8
  • [4] Quantitative determination of 3,3′-diindolylmethane in urine of individuals receiving indole-3-carbinol
    Sepkovic, DW
    Bradlow, HL
    Bell, M
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2001, 41 (1-2): : 57 - 63
  • [5] Indole-3-carbinol and prostate cancer
    Sarkar, FH
    Li, YW
    [J]. JOURNAL OF NUTRITION, 2004, 134 (12): : 3493S - 3498S
  • [6] Urinary 3,3′-Diindolylmethane: A Biomarker of Glucobrassicin Exposure and Indole-3-Carbinol Uptake in Humans
    Fujioka, Naomi
    Ainslie-Waldman, Cheryl E.
    Upadhyaya, Pramod
    Carmella, Steven G.
    Fritz, Vincent A.
    Rohwer, Charles
    Fan, Yunhua
    Rauch, Diane
    Le, Chap
    Hatsukami, Dorothy K.
    Hecht, Stephen S.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (02) : 282 - 287
  • [7] Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner
    Lee, SH
    Kim, JS
    Yamaguchi, K
    Eling, TE
    Baek, SJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (01) : 63 - 69
  • [8] Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium
    Chen, DZ
    Qi, M
    Auborn, KJ
    Carter, TH
    [J]. JOURNAL OF NUTRITION, 2001, 131 (12): : 3294 - 3302
  • [9] Development and validation of an HPLC method for the simultaneous quantification of indole-3-carbinol acetate, indole-3-carbinol, and 3,3′-diindolylmethane in mouse plasma, liver, and kidney tissues
    Moussata, Justin
    Wang, Zhijun
    Wang, Jeffrey
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2014, 958 : 1 - 9
  • [10] 3,3′-diindolylmethane, a major condensation product of indole-3-carbinol, is a patent estrogen in the rainbow trout
    Shilling, AD
    Carlson, DB
    Katchamart, S
    Williams, DE
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 170 (03) : 191 - 200